Amazon Stock Surges as Pharmacy Push Gains Traction

Amazon ( (AMZN) ) has risen by 12.03%. Read on to learn why.

Claim 30% Off TipRanks

Amazon’s shares climbed 12.03% over the past week, buoyed by growing optimism around both its core business and new health-related initiatives. Investors reacted positively to a reaffirmed Buy rating from Jefferies analyst Brent Thill, who set a $300 price target, versus a recent close of $233.65 near the stock’s 52‑week high. Wall Street sentiment remains firmly upbeat, with a Strong Buy consensus and an average target price of $284.34, implying further upside from current levels.

A key driver of enthusiasm is Amazon’s expanding presence in healthcare via its pharmacy unit. The company announced it will offer same‑day delivery of Eli Lilly’s newly approved Foundayo weight‑loss pill to about half of U.S. customers who already have access to Amazon’s same‑day service. By leveraging its logistics network to distribute a high‑demand obesity drug, Amazon is tapping into one of the fastest‑growing segments in the healthcare market, which investors see as a potential long‑term growth engine beyond e‑commerce and cloud computing.

Amazon Pharmacy will also stock Foundayo in kiosks at some of its primary care clinics, a move made easier by the pill’s lack of cold‑storage requirements compared with injectable weight‑loss drugs. This expanded availability aligns with Eli Lilly’s own direct‑to‑consumer push and positions Amazon as a critical channel for the drug’s rollout. The combination of bullish analyst coverage, strong technical momentum near 52‑week highs, and a credible strategy to monetize healthcare demand has helped power Amazon’s 12.03% stock jump over the last week.